Video: Profit – Indonesia's Jamu Industry Advances into Modern Wellness Business

Jakarta, CNBC Indonesia – According to BPOM (Food and Drug Supervisory Agency), Indonesia remains dependent on pharmaceutical imports despite the national herbal medicine industry’s potential economic value of up to Rp 350 trillion annually.

CEO of PT Ultra Sakti, Harun Pramono, stated that Indonesia has vast potential to become a major player in the herbal medicine industry, though efforts are still needed to improve traditional medicine quality.

However, meeting BPOM standards, including Good Traditional Medicine Manufacturing Practices (CPOTB), remains a challenge for herbal medicine SMEs, despite a domestic market covering 40% of Indonesia’s population.

PT Ultra Sakti, a pharmaceutical company producing and packaging over-the-counter (OTC) herbal medicines and health supplements, is actively promoting education among SMEs to standardise their herbal products. Currently, only 71 out of 20,000 registered herbal products have been upgraded to Standardised Herbal Medicine (OHT) status.

At Ultra Sakti, ongoing development of herbal and OTC products focuses on innovation in formula and packaging to cater to diverse market segments. The company is also targeting expansion beyond Java and internationally by strengthening sales channels.

How does the industry view efforts to elevate Indonesian jamu to standardised herbal products and integrate them into the modern wellness sector? Watch the full interview with Serliana Salsabila and PT Ultra Sakti CEO Harun Pramono on CNBC Indonesia’s Profit programme (Tuesday, 19 May 2026).